DJIA 16,374.76 23.38 0.14%
NASDAQ 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

company name or ticker
Company Photos
(Click to zoom)

3 Stocks Improving Performance Of The Drugs Industry

Amgen, Novartis Team Up; Bone Drug Positive in Phase III

Eli Lilly Is A Boring Stock... I Like Boring!

VHT, MRK, BMY, LLY: Large Outflows Detected at ETF

ESC- Case Builds For Jardiance

Bristol-Myers Inks Another Immuno-Oncology Drug Deal

Why Eli Lilly (LLY) Could Beat Earnings Estimates Again

Approval Of Repatha May Give Amgen A $5B Boost.

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval

See More Articles...